Comparative effects of estrogen on matrix metalloproteinases and cytokines in immortalized and primary human corneal epithelial cell cultures

Cornea

Volumn 25, Issue 4, 2006, Pages 454-459

  Suzuki, Tomo ^a   Sullivan, David A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Cell culture; Cornea; Cytokine; Estrogen; Matrix metalloproteinase

Indexed keywords

CYTOKINE; ESTRADIOL; ESTROGEN; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; INTERLEUKIN DERIVATIVE;

ARTICLE; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY; ADULT; AGED; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SIMIAN VIRUS 40; VIROLOGY; VIRUS CELL TRANSFORMATION;

ADULT; AGED; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; EPITHELIUM, CORNEAL; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

EID: 33745014599     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000220777.70981.46     Document Type: Article

References (39)

1. Suzuki T, Sullivan DA. Estrogen stimulation of pro-inflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells. Cornea. 2005;24:1004-1009.
2. Schaumberg DA, Buring JE, Sullivan DA, et al. Hormone replacement therapy and the prevalence of dry eye syndrome. JAMA. 2001;286:2114-2119.
3. Jakob F, Siggelkow H, Homann D, et al. Local estradiol metabolism in osteoblast- and osteoclast-like cells. J Steroid Biochem Mol Biol. 1997;61:167-174.
4. Ruben M. Contact lenses and oral contraceptives. Brit Med J. 1966;1:1110.
5. Riss B, Binder S, Riss P, et al. Corneal sensitivity during the menstrual cycle. Br J Ophthalmol. 1982;66:123-126.
6. Kiely PM, Carney LG, Smith G. Menstrual cycle variations of corneal topography and thickness. Am J Optom Physiol Opt. 1983;60:822-829.
7. Imafidon CO, Imafidon JE. Contact lenses in pregnancy. Brit J Obstet Gynecol. 1992;99:865-868.
8. Gurwood AS, Gurwood I, Gubman DT, et al. Idiosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci. 1995;72:29-33.
9. Verbeck B. Augenbefunde und stoffwechselverhalten bei einnahme von ovulationshemmern. Klin Mbl Augenheilk. 1973;162:612-621.
10. Christ T, Marquardt R, Stodtmeister R, et al. Zur Beeinflussung der tränenfilmaufreibzeit durch hormonale kontrazeptiva. Fortschr Ophthalmol. 1986;83:108-111.
11. Sorrentino C, Affinito P, Mattace, et al. Effect of hormone replacement therapy on postmenopausal ocular function. Minerva Ginecol. 1998;50:19-24.
12. 45Ca in rats after administration of a single dose of estrogens during the first days of postnatal life. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1974;191:85-91.
13. McCarty CA, Ng I, Waldron B, et al. Relation of hormone and menopausal status to outcomes following excimer laser photorefractive keratectomy in women. Melbourne excimer laser group. Aust N Z J Ophthalmol. 1996;24:215-222.
14. Midelfart A. Women and men - same eyes? Acta Ophthalmol Scand. 1996;74:589-592.
15. Chizek DJ, Franceschetti AT. Oral contraceptives: their side effects and ophthalmological manifestations. Surv Ophthalmol. 1969;14:90-105.
16. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
17. Kuiper GGJ, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor α and β. Endocr. 1997;138:863-870.
18. Skynner MJ, Sim JA, Herbison AE. Detection of estrogen receptor α and β messenger ribonucleic acids in adult gonadotropin-releasing hormone neurons. Endocrinol. 1999;140:5195-5201.
19. Brannan CI, Dees EC, Ingram RS, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990;10:28-36.
20. Smithson G, Couse JF, Lubahn DB, et al. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol. 1998;161:27-34.
21. Lubahn DB, Moyer JS, Golding TS, et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A. 1993;90:11162-11166.
22. Kuiper GGJ, Enmark E, Pelto-Huikko M, et al. Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996;93:5925-5930.
23. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science. 1994;266:1524-1527.
24. Couse JF, Curtis SW, Washburn TF, et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocr. 1995;9:1441-1454.
25. Shughrue P, Scrimo P, Lane M, et al. The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse. Endocrinol. 1997;138:5649-5652.
26. Hall JM, McDonnell DP. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinol. 1999;140:5566-5578.
27. Mitchner NA, Garlick C, Ben-Jonathan N. Cellular distribution and gene regulation of estrogen receptors α and β in the rat pituitary gland. Endocrinol. 1998;139:3976-3983.
28. McDonnell DP, Norris JD. Connections and regulation of the human estrogen receptor. Science. 2002;296:1642-1644.
29. Tsurusaki T, Aoki D, Kanetake H, et al. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia. J Clin Endocrinol Metab. 2003;88:1333-1340.
30. Lindberg MK, Moverare S, Skrtic S, et al. Estrogen receptor (ER)-β reduces ERα-regulated gene transcription, supporting a "Ying Yang" relationship between ERα and ERβ in mice. Mol Endocrinol. 2003;17:203-208.
31. Frasor J, Barnett DH, Danes JM, et al. Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. Endocrinology. 2003;144:3159-3166.
32. Lau KM, LaSpina M, Long J, et al. Expression of estrogen receptor (ER)- α and ER-β in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res. 2000;60:3175-3182.
33. Suzuki T, Kinoshita Y, Tachibana M, et al. Expression of sex steroid hormone receptors in human cornea. Curr Eye Res. 2001;22:28-33.
34. Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000;41:1703-1709.
35. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci. 1990;31:1779-1788.
36. Sandeman SR, Faragher RG, Allen MC, et al. Does MMP-2 expression and secretion change with increasing serial passage of keratocytes in culture? Mech Ageing Dev. 2001;122:157-167.
37. Hansell EJ, Frisch SM, Tremble P, et al. Simian virus 40 transformation alters the actin cytoskeleton, expression of matrix metalloproteinases and inhibitors of metalloproteinases, and invasive behavior of normal and ataxia-telangiectasia human skin fibroblasts. Biochem Cell Biol. 1995;73:373-389.
38. Piedagnel R, Murphy G, Ronco PM, et al. Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor. J Biol Chem. 1999;15;274:1614-1620.
39. Xu KP, Ding Y, Ling J, et al. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:813-820.